Session Details

F042 The Pregnant Pause: How to Evaluate and Treat Your Pregnant Patients

Sat, Mar 20, 3:30 PM - 5:30 PM
2 CME Available Forum

DESCRIPTION

Dermatologists face multiple challenges when evaluating and treating the pregnant patient. Treatment of common dermatoses such as acne and atopic dermatitis is difficult; risks to the fetus limit the number of evidence-based studies concerning drug therapy. Concerning melanocytic lesions, do nevi change during pregnancy, and if melanoma is diagnosed, is there a poor prognosis? Infections and infestations may present a risk for mother and fetus, and treatment options may be limited. Several dermatoses are specific for pregnancy; early recognition and management may be important to prevent adverse effects on the fetus and/or mother.

LEARNING OBJECTIVES

1.

Develop treatment plans for pregnant patients with common dermatologic diagnoses.

2.

Evaluate and manage melanocytic lesions in the pregnant patient.

3.

Recognize and treat specific dermatoses of pregnancy.

SCHEDULE

3:30 PM

Introduction

Marcia S. Driscoll, MD, FAAD

3:35 PM

Evaluation and Management of Nevi and Melanoma in the Pregnant Patient

3:55 PM

Treatment of Acne in the Pregnant Patient

Jonette Elizabeth Keri, MD, PhD, FAAD

4:15 PM

Specific Dermatoses of Pregnancy

Miriam Keltz Pomeranz, MD, FAAD

4:35 PM

Treatment of infections and Infestations in the Pregnant Patient

Jenny Eileen Murase, MD, FAAD

4:55 PM

Treatment of Atopic Dermatitis in the Pregnant Patient

Marcia S. Driscoll, MD, FAAD

5:15 PM

Questions and Discussion

DIRECTOR

Marcia S. Driscoll, MD, FAAD

Marcia S. Driscoll, MD, FAAD

SPEAKERS

Jonette Elizabeth Keri, MD, PhD, FAAD

Jonette Elizabeth Keri, MD, PhD, FAAD

Jenny Eileen Murase, MD, FAAD

Jenny Eileen Murase, MD, FAAD

PAFMG/UCSF

Miriam Keltz Pomeranz, MD, FAAD

Miriam Keltz Pomeranz, MD, FAAD

New York University

DISCLOSURES

Marcia S. Driscoll, MD, FAAD

UpToDate, Inc – Other(Honoraria);

Jonette Elizabeth Keri, MD, PhD, FAAD

Almirall – Consultant(Fees); Galderma USA – Investigator(Grants/Research Funding); L'Oreal – Advisory Board(Honoraria); Ortho Dermatologics – Advisory Board(Honoraria); Primus Pharmaceuticals – Advisory Board(Honoraria); Sanofi – Advisory Board(Honoraria);

Jenny Eileen Murase, MD, FAAD

AbbVie – Consultant(Honoraria), Speaker/Faculty Education(Honoraria); Apogee Therapeutics – Consultant (1099 relationship)(Honoraria); Attovia Therapeutics – Consultant (1099 relationship)(Honoraria); Blueprint Medicines – Advisory Board(Honoraria); Blueprints Medicine – Speaker(Honoraria); Eli Lilly – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Speaker/Faculty Education(Honoraria); Galderma – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Speaker(Honoraria); Incyte – Advisory Board(Honoraria); Leo Pharma – Advisory Board(Honoraria); Leo Pharma Inc – Speaker/Faculty Education(Honoraria); Pfizer Inc. – Advisory Board(Honoraria), Speaker(Honoraria); Phothera – Advisory Board(Honoraria); Regeneron – Speaker/Faculty Education(Honoraria); Sanofi – Speaker(Honoraria); Sanofi/Regeneron – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria); UCB – Advisory Board(Honoraria), Consultant(Honoraria), Speaker/Faculty Education(Honoraria); UpToDate – Consultant(Honoraria);

Miriam Keltz Pomeranz, MD, FAAD

Procter & Gamble Company – Advisory Board(Fees); UpToDate – Other(Patent royalties or other compensation for Intellectual Property Rights);